Your AI-Trained Oncology Knowledge Connection!

Brandon Bernard, MD, MPH

home / authors / brandon-bernard-md-mph

Articles

POINT-Prostate Cancer Genomic Analysis: Routine or Research Only?

Brandon Bernard, MD, MPH;Thomas W. Flaig, MD

December 17th 2018

In this side of the Point/Counterpoint, Drs. Bernard and Flaig state that genomic testing should be routine in the management of prostate cancer patients.

Complications of Androgen Deprivation Therapy in Men With Prostate Cancer

Tejas Patil, MD;Brandon Bernard, MD, MPH

September 18th 2018

This article summarizes the key side effects associated with ADT for the treatment of prostate cancer and discusses strategies to optimize management.

Post-Prostatectomy Radiation Therapy: Patient Selection, Timing, Imaging, and Therapy Intensification

Tyler P. Robin, MD, PhD;Paul D. Maroni, MD;Bennett B. Chin, MD;Francisco G. La Rosa, MD;Brandon Bernard, MD, MPH;Thomas J. Pugh, MD

July 15th 2018

A 62-year-old man with prostate adenocarcinoma elected to proceed with radical prostatectomy as definitive management. After his pathology report showed stage IIIB disease, he elected for observation. What happened next?